If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeladon Pharmaceuticals Regulatory News (CEL)

  • This share is currently suspended. It was suspended at a price of 13.40
  • There is currently no data for CEL

Treasury Stock

10 Jun 2005 15:38

Celsis International PLC10 June 2005 Celsis International plc Acquires Treasury Shares The Company announces that on 8 June 2005 it purchased 775,000 of its ordinary1p shares at 36p per share to be held as Treasury Shares. Enquiries: Celsis International plc Tel: 01638 600 151 Christian Madrolle, Finance Director & Company Secretary This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th Aug 20058:00 amRNSDirector/PDMR Shareholding
26th Jul 20055:07 pmRNSResult of AGM
26th Jul 20057:00 amRNSAGM Statement
18th Jul 20054:35 pmRNSDividend Declaration
11th Jul 20054:58 pmRNSHolding(s) in Company
30th Jun 200511:42 amRNSAnnual Report and Accounts
28th Jun 20057:01 amRNSRe: Share Capital
10th Jun 20053:38 pmRNSTreasury Stock
6th Jun 20054:59 pmRNSDirector Shareholding
2nd Jun 200511:03 amRNSHolding(s) in Company
31st May 20059:07 amRNSDirector Shareholding
24th May 20057:01 amRNSFinal Results
16th May 20054:08 pmRNSNotice of Results
1st Apr 20057:00 amRNSTrading Statement
1st Mar 20057:01 amRNSBoard Change
18th Feb 20054:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.